Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Amazon launches first Alexa health services

Has been granted permission to transmit patient data

- PMLiVE

Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)

Authors: Keir LoIacono, John Rodriguez, Daniel J. O’Connor, James R. Nitzkorski, MD*, Christopher G. Twitty, PhDAffiliations: OncoSec Medical Incorporated, San Diego, CA, and Pennington, NJ, *Division of Surgical Oncology, Vassar...

Oncosec

- PMLiVE

Roivant forms Asian cell therapy ‘vant’, with Medigene’s help

Latest venture taps into Asian talent and markets

- PMLiVE

Teva’s migraine injection approved in Europe

Third anti-CGRP treatment to hit the market

- PMLiVE

Janssen’s CAR-T gains PRIME status in Europe

EMA fast-track could help Janssen close gap

- PMLiVE

Synergy Worldwide opens New York office

The move is part of its business growth strategy

- PMLiVE

AVEO warns EU approval of Fotivda could be at risk

Concerns arose with overall survival data

- PMLiVE

Biogen’s Spinraza overpriced, says ICER

Cost watchdog warns high price puts pressure on US health system

- PMLiVE

Pfizer gets EU nod for Tagrisso rival Vizimpro

Five year survival still only 12%

What role for pharma in helping to deliver integrated care?

Steve How and Paul Midgley, of Wilmington Healthcare, explore how pharma can support local health economies in providing joined-up, holistic services

Wilmington Healthcare

Novartis day

Novartis claims first place for psoriasis drug Cosentyx in China

Trial data from China helped support filing

- PMLiVE

Avenir Global acquires UK communications firm Hanover

Avenir says it aims to build a “powerhouse of specialist communications firms”

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links